🏠

🤯 Market Panic! 📉 Fears Rise & Crash 💥

May 18, 2026 | Author

Markets

🎧 Audio Summaries
English flag
French flag
German flag
Japanese flag
Korean flag
Mandarin flag
Spanish flag
🛒 Shop on Amazon

🧠Quick Intel


  • Dow E-minis were down 322 points, or 0.65%, and S&P 500 E-minis were down 30.5 points, or 0.41%, at 7:19 a.m. ET.
  • The benchmark 10-year Treasury yield rose as high as 4.631% earlier in the day, its highest level since February 2025.
  • Brent crude futures were trading at $110.66 a barrel following a drone strike on a nuclear power plant in the United Arab Emirates, increasing the probability of a Fed rate hike to over 40% in January.
  • Nvidia shares have risen 36% from a March low, and the Philadelphia SE Semiconductor Index has surged more than 60% this year.
  • Dominion Energy jumped 14.2% after Bloomberg News reported a potential NextEra Energy acquisition at approximately $66 billion.
  • UnitedHealth Group fell 4.7% following Berkshire Hathaway’s sale of its stock holdings, including in the health insurer.
  • Regeneron shares fell 11.8% after its experimental melanoma treatment missed the main goal in a late-stage trial.

    • 📝Summary


    U.S. stock index futures dipped on Monday as rising Treasury yields, peaking at 4.631% in February 2025, and elevated Brent crude futures at $110.66 a barrel influenced trading. Simultaneously, efforts to resolve the Iran war stalled following a drone strike in the United Arab Emirates, increasing the likelihood of a Federal Reserve interest rate hike. The Dow E-minis decreased by 322 points, while the S&P 500 E-minis fell 30.5 points. Investors are anticipating Nvidia’s earnings and observing Dominion Energy’s potential acquisition by NextEra Energy. UnitedHealth Group shares declined after Berkshire Hathaway’s divestment, and Regeneron’s melanoma treatment trial results disappointed. These developments highlight ongoing economic uncertainty and shifts within the market landscape.

    💡Insights

    ▼


    MARKET SENTIMENT AND FED WATCH
    The global stock market experienced a cautious start to the week, with U.S. stock index futures declining as rising Treasury yields and elevated oil prices fueled investor concerns. The 10-year Treasury yield reached a high of 4.631% – its highest since February 2025 – driven by increased oil prices stemming from stalled efforts to end the Iran-Israel conflict and a subsequent drone attack on a nuclear power plant in the United Arab Emirates. This surge in yields has prompted worries about potential impacts on equity valuations, particularly within growth and technology sectors, and increased pressure on governments with substantial debt burdens. The market’s recent rally, spurred by optimism surrounding artificial intelligence, was abruptly halted following Friday’s bond market turbulence. The probability of a January interest rate hike by the U.S. Federal Reserve has climbed to over 40% according to CME’s FedWatch, reflecting hotter-than-expected inflation readings. Trading volumes were subdued as investors awaited key economic data releases and corporate earnings announcements.

    CORPORATE EARNINGS AND INDUSTRY TRENDS
    Several significant corporate earnings events are scheduled this week, providing crucial insights into the health of the U.S. economy. Nvidia (NVDA), the world’s most valuable company, is set to report its first-quarter results on Wednesday, following a remarkable 36% surge from a March low. The Philadelphia Semiconductor Index (SOX) has demonstrated strong growth, reflecting robust demand for artificial intelligence-related chips. Walmart (WMT), the world’s largest retailer, will also report earnings this week, offering a gauge of consumer behavior in the face of higher energy prices and broader inflation. Beyond these headline reports, significant developments include Dominion Energy’s (D) stock jumping 14.2% due to discussions between Dominion and NextEra Energy (NEE) regarding a potential acquisition. Conversely, UnitedHealth Group (UNH) shares declined by 4.7% following Berkshire Hathaway’s (BRK.A) sale of its smaller stock holdings, including a substantial position in the health insurer.

    KEY ECONOMIC INDICATORS AND FED POLICY
    The market’s reaction is heavily influenced by upcoming economic data releases and the evolving policy stance of the Federal Reserve. The minutes of the Fed’s December meeting, due on Wednesday, will be closely scrutinized for clues about the central bank’s intentions regarding future interest rate decisions. The upcoming transition of former Governor Kevin Warsh to chair presents an early test, balancing the White House’s desire for lower borrowing costs with the more hawkish tone adopted by Fed officials. Furthermore, Regeneron’s (REGN) disappointing results in a late-stage melanoma trial, resulting in a 11.8% stock drop, highlights the ongoing challenges within the pharmaceutical sector. Overall, investors are navigating a complex landscape characterized by uncertainty surrounding inflation, interest rates, and corporate earnings, making the week’s events particularly pivotal.

    Related Articles